Diego Díaz-García, Medical Oncologist, CEO, Founder at CánCare – Advanced Specialty in Oncology, shared a post on X about a paper by Thomas Kisby et al., published in Nature Reviews Clinical Oncology.
“Glioblastoma can begin to regrow just days after surgery.
Locoregional nanotechnologies offer a way to target the resection margin during this critical window.
A promising shift in neuro-oncology strategies.”
Title: Targeting the glioblastoma resection margin with locoregional nanotechnologies
Authors: Thomas Kisby, Gerben R. Borst, David J. Coope, Kostas Kostarelos
Read The Full Article at Nature Reviews Clinical Oncology.
More posts featuring Diego Díaz García on OncoDaily.
